Pharmacogenomics is the research of how genes influence a person’s reaction to drugs. This comparatively new area brings together pharmacology and genomics to create efficient, safe drugs and doses that will be customized to a person’s genetic make-up. Innovations are new idea, device or process. Innovations are the application of better solutions that meet new requirements, inarticulated needs or existing market needs. It is proficient through more effective products, processes, services, technologies, or new ideas that are readily available to markets, governments and society. Innovations are something original and novel, as a significant, new that “breaks into” the market or society.
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Research Article: Pharmacoeconomics: Open Access
Commentary: Pharmacoeconomics: Open Access
Commentary: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Editorial: Pharmacoeconomics: Open Access
Posters & Accepted Abstracts: Journal of Formulation Science & Bioavailability
Posters & Accepted Abstracts: Journal of Formulation Science & Bioavailability
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Pharmacognosy & Natural Products
Scientific Tracks Abstracts: Journal of Pharmacognosy & Natural Products
Posters: Journal of Bioanalysis & Biomedicine
Posters: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Pharmacoeconomics: Open Access received 106 citations as per Google Scholar report